Pharming (PHAR) Times Interest Earned (2020 - 2023)
Pharming's (PHAR) quarterly Times Interest Earned came in at -$3.01 in Q3 2023, down 146.3% YoY from $6.51 in Q3 2022, and down 146.3% on a QoQ basis from $6.51 in Q3 2022.
Pharming (PHAR) Times Interest Earned (2020 - 2023) Analysis & Trends
Pharming (PHAR) has 4 years of Times Interest Earned data on file, last reported at -$3.01 in Q3 2023.
- Quarterly Times Interest Earned fell 146.3% year-over-year to -$3.01 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $22.76 (up 92.34% YoY) and the FY2025 annual result came in at $2.67, up 338.29% from the prior year.
- Times Interest Earned eased to -$3.01 in Q3 2023, from $6.51 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1027.1 in Q4 2020 to a low of -$2447.2 in Q4 2021.
- A 4-year average of -$235.9 and a median of $0.56 in 2020 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned plunged 338.25% — and 2022, when it soared 1077.31%.
- Tracing PHAR's Times Interest Earned over 4 years: stood at $1027.1 in 2020, then sank by 338.25% to -$2447.2 in 2021, then surged by 100.27% to $6.51 in 2022, then slumped by 146.3% to -$3.01 in 2023.
- The last three Times Interest Earned figures came in at -$3.01 (Q3 2023), $6.51 (Q3 2022), and -$2447.2 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -3.01 |
| Sep 30, 2022 | 6.51 |
| Dec 31, 2021 | -2,447.19 |
| Sep 30, 2021 | -0.67 |
| Dec 31, 2020 | 1,027.15 |
| Sep 30, 2020 | 1.79 |